Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-17-014037
Filing Date
2017-12-01
Accepted
2017-12-01 06:15:18
Documents
8
Period of Report
2017-12-01
Effectiveness Date
2017-12-01

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 381400
2 image_001.jpg GRAPHIC 16639
3 image_002.jpg GRAPHIC 2292
4 image_003.jpg GRAPHIC 3168
5 image_004.jpg GRAPHIC 3175
6 image_005.jpg GRAPHIC 3170
7 image_006.jpg GRAPHIC 111047
8 image_007.jpg GRAPHIC 138753
  Complete submission text file 0001493152-17-014037.txt   766386
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37428 | Film No.: 171232661
SIC: 2834 Pharmaceutical Preparations